Andere Sprachen Bausch Health Companies Inc. Toronto S.E.

Aktien

A2JQ1X

CA0717341071

BHC

Markt geschlossen - Toronto S.E. Andere Börsenplätze 22:00:00 31.05.2024			% 5 Tage	% 1. Jan.
8,95 ^CAD	+4,19 %		+2,87 %	-15,71 %

23.05.	Bausch Health kündigt breitere öffentliche Arzneimittelversorgung für Uceris in Kanada an	MT
17.05.	Bausch Health Companies Inc. und Salix Pharmaceuticals stellen auf der Digestive Disease Week 2024 neue Daten aus der Phase-2-Studie mit Amiselimod bei aktiver Colitis ulcerosa vor	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bausch Health Announces Wider Public Drug Plan Coverage for Uceris in Canada	23.05.
Bausch Health Companies Inc. and Salix Pharmaceuticals to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024	17.05.
RBC Notes Updates on Bausch Xifaxan Patent Litigation with Norwich	15.05.
Bausch Health Companies Inc. Approves Directorate Appointments	15.05.
RBC Noes Bausch Health Filing For Rehearing in Appellate Court	13.05.
RBC Lowers Bausch Health Target to US$10, Maintains Sector Perform	03.05.
Bausch Health Shares Fall Following Q1 Results	02.05.
Bausch Health Q1 Net Loss Narrows on Higher Revenue, Confirms 2024 Revenue Guidance	02.05.
Transcript : Bausch Health Companies Inc., Q1 2024 Earnings Call, May 02, 2024	02.05.
Bausch Health Companies Inc. Reaffirms Earnings Guidance for the Full Year 2024	02.05.
Bausch Health Companies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02.05.
Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year	01.05.
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says	23.04.
RBC Previews Bausch Health's Q1, Trims Target to US$11	23.04.
BAUSCH HEALTH COMPANIES INC. : RBC Capital Markets n'est pas inspiré par le dossier	23.04.
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	12.04.
Bausch wins US appeal to block Alvogen generic of diarrhea drug	11.04.
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan	11.04.
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	08.04.
RBC Raises Bausch Health Target to US$12, Maintains Sector Perform, on Upcoming Xifaxan Litigation Ruling	05.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bausch Health Companies Inc. Toronto S.E.

Aktien

A2JQ1X

CA0717341071

BHC

Andere Sprachen

Filter